| For: | Ashtari S, Pourhoseingholi MA, Sharifian A, Zali MR. Hepatocellular carcinoma in Asia: Prevention strategy and planning. World J Hepatol 2015; 7(12): 1708-1717 [PMID: 26140091 DOI: 10.4254/wjh.v7.i12.1708] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i12/1708.htm |
| Number | Citing Articles |
| 1 |
Xue Bai, Zhenzhen Liu, Xiaojian Shao, Di Wang, Encheng Dong, Yan Wang, Chung-I Wu, Yunfei Yuan, Xuemei Lu, Chunyan Li, Mitesh J. Borad. The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma. PLOS ONE 2019; 14(2) doi: 10.1371/journal.pone.0211581
|
| 2 |
Li Gao, Ke-xin Wang, Nan-nan Zhang, Jia-qi Li, Xue-mei Qin, Xiu-ling Wang. 1H Nuclear Magnetic Resonance Based Metabolomics Approach Reveals the Metabolic Mechanism of (−)-5-Hydroxy-equol against Hepatocellular Carcinoma Cells in Vitro. Journal of Proteome Research 2018; 17(5) doi: 10.1021/acs.jproteome.7b00853
|
| 3 |
Pin Li, Yuanyuan Shi, Baosheng Zhao, Wenhui Xu, Ziying Xu, Jingxuan Zhang, Zhaojuan Guo, Yucong Bi, Tieshan Wang, Yu Qin, Ting Wang. Pharmacological evaluation and mechanistic study of compound Xishu Granule in hepatocellular carcinoma. Journal of Traditional Chinese Medical Sciences 2020; 7(3) doi: 10.1016/j.jtcms.2020.07.006
|
| 4 |
Zhi-Hua Zhang, Li Xin Li, Ping Li, Shao-Cheng Lv, Bing Pan, Qiang He. Sirolimus in Liver Transplant Recipients with Hepatocellular Carcinoma: An Updated Meta-Analysis. Journal of Investigative Surgery 2019; 32(7) doi: 10.1080/08941939.2018.1447053
|
| 5 |
Ming Song, Yixin Zhuge, Yuqi Tu, Jie Liu, Wenjuan Liu. The Multifunctional Role of KCNE2: From Cardiac Arrhythmia to Multisystem Disorders. Cells 2024; 13(17) doi: 10.3390/cells13171409
|
| 6 |
Yongjuan Wu, Guangyuan Cheng, Jun Han, Qingsong Yang. Myosteatosis and the survival of patients with hepatocellular carcinoma: a meta-analysis. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01671-6
|
| 7 |
Wei Wu, Jun-Ling Yang, Yi-Lang Wang, Han Wang, Min Yao, Li Wang, Juan-Juan Gu, Yin Cai, Yun Shi, Deng-Fu Yao. Reversal of multidrug resistance of hepatocellular carcinoma cells by metformin through inhibiting <i>NF-κB</i> gene transcription. World Journal of Hepatology 2016; 8(23): 985-993 doi: 10.4254/wjh.v8.i23.985
|
| 8 |
Takuji Torimura, Hideki Iwamoto. Treatment and the prognosis of hepatocellular carcinoma in Asia. Liver International 2022; 42(9) doi: 10.1111/liv.15130
|
| 9 |
Dahai Wei, Yongyi Zeng, Xiaohua Xing, Hongzhi Liu, Minjie Lin, Xiao Han, Xiaolong Liu, Jingfeng Liu. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics. Journal of Proteome Research 2016; 15(2) doi: 10.1021/acs.jproteome.5b00838
|
| 10 |
Zixu Yan, Feng Chen, Dexing Kong. Liver Venous Tree Separation via Twin-Line RANSAC and Murray’s Law. IEEE Transactions on Medical Imaging 2017; 36(9) doi: 10.1109/TMI.2017.2722237
|
| 11 |
Ayesha Khalid, Tabinda Hussain, Sobia Manzoor, Muhammad Saalim, Saba Khaliq. PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma. Tumor Biology 2017; 39(6) doi: 10.1177/1010428317705754
|
| 12 |
Oleg V. Grinchuk, Surya P. Yenamandra, Ramakrishnan Iyer, Malay Singh, Hwee Kuan Lee, Kiat Hon Lim, Pierce Kah‐Hoe Chow, Vladamir A. Kuznetsov. Tumor‐adjacent tissue co‐expression profile analysis reveals pro‐oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma. Molecular Oncology 2018; 12(1) doi: 10.1002/1878-0261.12153
|
| 13 |
Yi-Ren Lin, Wen-Jing Yang, Guo-Wang Yang. Prognostic and immunological potential of PPM1G in hepatocellular carcinoma. Aging 2021; 13(9) doi: 10.18632/aging.202964
|
| 14 |
Merin Babu, Ashok Sebastian Komaranchath, Arun Valsan, Arun R. Warrier, Rakesh MP, Wesley M. Jose, Nikhil K. Haridas, Sumi Soman, Manjima P. Nair, Shine Sadasivan, Abhinav Menon, Mohammed Thabrez, Keechilat Pavithran. Safety and efficacy of atezolizumab/bevacizumab in unresectable hepatocellular carcinoma—a multicentric study. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-14400-9
|
| 15 |
Mu Jie, Liu Hai-Xia, Tang Fei-Fei, Liu Shu-Ling, Feng Tian-Yi, Wang Xue-Qian, Wang Qing-Guo, Cheng Fa-Feng. Systematic Investigation of Berberine for Treating Hepatocellular Carcinoma Based on Network Pharmacology. Digital Chinese Medicine 2019; 2(3) doi: 10.1016/j.dcmed.2019.12.001
|
| 16 |
Yi-Wen Hsiao, Lu-Ting Chiu, Ching-Hsuan Chen, Wei-Liang Shih, Tzu-Pin Lu. Tumor-Infiltrating Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas. Genes 2019; 10(8) doi: 10.3390/genes10080630
|
| 17 |
Darren J. H. Tan, Chloe Wong, Cheng Han Ng, Chen Wei Poh, Sneha Rajiv Jain, Daniel Q. Huang, Mark D. Muthiah. A Meta-Analysis on the Rate of Hepatocellular Carcinoma Recurrence after Liver Transplant and Associations to Etiology, Alpha-Fetoprotein, Income and Ethnicity. Journal of Clinical Medicine 2021; 10(2) doi: 10.3390/jcm10020238
|
| 18 |
Ping‐Jen Hu, Chia Yu Pai, Yen‐Hsiang Wang, Ming‐Yao Chen, Chun‐Han Cheng, Huan‐Lin Chen, I‐Tsung Lin, Chia‐Hsien Wu, Yuan‐Kai Lee, Po‐Wei Huang, Ming‐Jong Bair. The impact of chronic alcohol consumption on hepatocellular carcinoma: Insights from a cohort study in eastern Taiwan. Advances in Digestive Medicine 2026; 13(2) doi: 10.1002/aid2.70030
|
| 19 |
M. H. Garba, M. L. Sherifat, A. O. Abdul-Majeed, L. M. Hafsa, A.B. Awal, A. A. Sa’adu, B. J. Lekene. Hepato-protective potentials of Sterculia setigera stem-bark extract on acetominophen induced hepato toxicity in Wistar albino rats. Journal of Medicinal Plants Research 2018; 12(29) doi: 10.5897/JMPR2018.6672
|
| 20 |
Hendra Susanto, Dinda Tri Yunisa, Ahmad Taufiq, Wira Eka Putra, Nur Raiyan Jannah, Shabrina Andira Putri, Ikke Astrid Dewi, Qori Dini Ayu Febriyanti, Ikfi Nihayatul Mufidah. Anti fibrogenesis effect of green materials Moringa oleifera leaf powder (MOLP) on the progression of hepatocellular carcinoma. INTERNATIONAL CONFERENCE ON LIFE SCIENCES AND TECHNOLOGY (ICoLiST 2020) 2021; 2353 doi: 10.1063/5.0052554
|
| 21 |
Min Su, Xueqin Wang, Gang Cao, Li Sun, Rodney J Y Ho, Yanquan Han, Yan Hong, Deling Wu. Prediction of the potential mechanism of compound gingerol against liver cancer based on network pharmacology and experimental verification. Journal of Pharmacy and Pharmacology 2022; 74(6) doi: 10.1093/jpp/rgac002
|
| 22 |
Manisha M Ratnaparkhi, Chanda R Vyawahare, Nageswari R Gandham. Hepatitis B virus genotype distribution and mutation patterns: Insights and clinical implications for hepatitis B virus positive patients. World Journal of Experimental Medicine 2025; 15(2): 102395 doi: 10.5493/wjem.v15.i2.102395
|
| 23 |
K.-N. Kwok, K.-M. Chueng, S.J.-L. Lam, M. Seo, C.Y. Lau, P.Y.-M. Woo, H.-S. Lam, S.-M. Yip, S. Lam, O.-P. Chiu, W.W.Y. Sung, H.H.-W. Liu, K.K.-H. Bao, J.C.-H. Chow, S.K.-K. Ng, H.H.-Y. Yiu, D.C.C. Lam. Development of a novel routine blood-based AI model for hepatocellular carcinoma screening—a territory-wide study. ESMO Gastrointestinal Oncology 2025; 10 doi: 10.1016/j.esmogo.2025.100241
|
| 24 |
Byung Gyu Kim, Neung Hwa Park, Seung Bum Lee, Soyoung Jeon, Jae Ho Park, Seok Won Jung, In Du Jeong, Sung‐Jo Bang, Jung Woo Shin. The risk of hepatocellular carcinoma within and beyond the first 5 years of entecavir in Korean patients with chronic hepatitis B. Liver International 2018; 38(12) doi: 10.1111/liv.13938
|
| 25 |
L.-T. Chen, E. Martinelli, A.-L. Cheng, G. Pentheroudakis, S. Qin, G.S. Bhattacharyya, M. Ikeda, H.-Y. Lim, G.F. Ho, S.P. Choo, Z. Ren, H. Malhotra, M. Ueno, B.-Y. Ryoo, T.C. Kiang, D. Tai, A. Vogel, A. Cervantes, S.-N. Lu, C.-J. Yen, Y.-H. Huang, S.-C. Chen, C. Hsu, Y.-C. Shen, J. Tabernero, Y. Yen, C.-H. Hsu, T. Yoshino, J.-Y. Douillard. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO. Annals of Oncology 2020; 31(3) doi: 10.1016/j.annonc.2019.12.001
|
| 26 |
Emily Kinsey, Hannah M. Lee. Management of Hepatocellular Carcinoma in 2024: The Multidisciplinary Paradigm in an Evolving Treatment Landscape. Cancers 2024; 16(3) doi: 10.3390/cancers16030666
|
| 27 |
Ahan Bhatt, Jennifer Wu. Immunotherapy for recurrent hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(15): 2261-2271 doi: 10.3748/wjg.v29.i15.2261
|
| 28 |
Anna Buttell, Wei Qiu. The action and resistance mechanisms of Lenvatinib in liver cancer. Molecular Carcinogenesis 2023; 62(12) doi: 10.1002/mc.23625
|
| 29 |
Jörg Lehner, Thomas B. Brunner. Bedeutung des Multidisziplinären Tumorboards in der Behandlung des hepatozellulären Karzinoms und des cholangiozellulären Karzinoms. Die Onkologie 2026; 32(5) doi: 10.1007/s00761-026-01938-x
|
| 30 |
Li Gao, Xiao-dong Wang, Yang-yang Niu, Dan-dan Duan, Xue Yang, Jian Hao, Cui-hong Zhu, Dan Chen, Ke-xin Wang, Xue-mei Qin, Xiong-zhi Wu. Molecular targets of Chinese herbs: a clinical study of hepatoma based on network pharmacology. Scientific Reports 2016; 6(1) doi: 10.1038/srep24944
|
| 31 |
Qungang Shan, Jingbiao Chen, Tianhui Zhang, Ronghua Yan, Jun Wu, Yunhong Shu, Zhuang Kang, Bingjun He, Zhongping Zhang, Jin Wang. Evaluating histologic differentiation of hepatitis B virus-related hepatocellular carcinoma using intravoxel incoherent motion and AFP levels alone and in combination. Abdominal Radiology 2017; 42(8) doi: 10.1007/s00261-017-1107-6
|
| 32 |
Marcin Ciecholewski, Michał Kassjański. Computational Methods for Liver Vessel Segmentation in Medical Imaging: A Review. Sensors 2021; 21(6) doi: 10.3390/s21062027
|
| 33 |
Juferdy Kurniawan, Rino A. Gani, Irsan Hasan, Andri S. Sulaiman, Cosmas R. A. Lesmana, Chyntia O. M. Jasirwan, Kemal F. Kalista, Saut H. H. Nababan, Steven Zulkifly. The Improvement in 1-Year Survival Rate of Patients with Hepatocellular Carcinoma BCLC Stage A and B after the Implementation of Comprehensive Management. Journal of Gastrointestinal Cancer 2020; 51(3) doi: 10.1007/s12029-019-00298-7
|
| 34 |
Mubarak A. Alamri. Bioinformatics and network pharmacology-based study to elucidate the multi-target pharmacological mechanism of the indigenous plants of Medina valley in treating HCV-related hepatocellular carcinoma. Saudi Pharmaceutical Journal 2023; 31(6) doi: 10.1016/j.jsps.2023.04.003
|
| 35 |
Chan Thida, Akriti Pokhrel, Lishi Sun, Richard Wu, Vijay Jaswani, Jen C. Wang. Hemorrhagic Brain Metastasis as an Initial Presentation of Hepatocellular Carcinoma in a Patient With Alcohol-Related Liver Cirrhosis: A Case Report and Review of Literature. Journal of Investigative Medicine High Impact Case Reports 2022; 10 doi: 10.1177/23247096221117788
|
| 36 |
Eaint Chu Moe Myint, Slawomir Wozniak. Hepatocellular carcinoma – a complicated matter. Medical Journal of Cell Biology 2023; 11(4) doi: 10.2478/acb-2023-0020
|
| 37 |
Chyntia Olivia Maurine Jasirwan, Irsan Hasan, Andri Sanityoso Sulaiman, Cosmas Rinaldi A. Lesmana, Juferdy Kurniawan, Kemal Fariz Kalista, Saut Horas Nababan, Rino Alvani Gani. Risk factors of mortality in the patients with hepatocellular carcinoma: A multicenter study in Indonesia. Current Problems in Cancer 2020; 44(1) doi: 10.1016/j.currproblcancer.2019.05.003
|
| 38 |
Amirhossein Davoodvandi, Sahand Sadeghi, Seyed Mohammad Amin Alavi, Seyedeh Shaghayegh Alavi, Ameneh Jafari, Haroon Khan, Michael Aschner, Hamed Mirzaei, Mehran Sharifi, Zatollah Asemi. The therapeutic effects of berberine for gastrointestinal cancers. Asia-Pacific Journal of Clinical Oncology 2024; 20(2) doi: 10.1111/ajco.13941
|
| 39 |
Chang Tan, Jingyi Cao, Lu Chen, Xiaochen Xi, Siqi Wang, Yumin Zhu, Liuqing Yang, Longteng Ma, Dong Wang, Jianhua Yin, Ti Zhang, Zhi John Lu. Noncoding RNAs Serve as Diagnosis and Prognosis Biomarkers for Hepatocellular Carcinoma. Clinical Chemistry 2019; 65(7) doi: 10.1373/clinchem.2018.301150
|
| 40 |
Edward John Gane, Michael R. Charlton, Rosmawati Mohamed, Jose Decena Sollano, Kyaw Soe Tun, Thuy Thi Thu Pham, Diana Alcantara Payawal, Rino Alvani Gani, David Handojo Muljono, Subrat Kumar Acharya, Hui Zhuang, Akash Shukla, Kaushal Madan, Neeraj Saraf, Satyendra Tyagi, Karam Romeo Singh, Ian Homer Yee Cua, Ganbolor Jargalsaikhan, Davadoorj Duger, Wattana Sukeepaisarnjaroen, Hery Djagat Purnomo, Irsan Hasan, Laurentius Adrianto Lesmana, Cosmas Rinaldi Adithya Lesmana, Khin Pyone Kyi, Win Naing, Allampura Chandrashekar Ravishankar, Sanjay Hadigal. Asian consensus recommendations on optimizing the diagnosis and initiation of treatment of hepatitis B virus infection in resource‐limited settings. Journal of Viral Hepatitis 2020; 27(5) doi: 10.1111/jvh.13244
|
| 41 |
Tung Nguyen Thanh Uong, Mee Sun Yoon, Kyung-Hwa Lee, Hoon Hyun, Taek-Keun Nam, Jung-Joon Min, Huy Phuoc Quang Nguyen, Sang-Ki Kim. Live cell imaging of highly activated natural killer cells against human hepatocellular carcinoma in vivo. Cytotherapy 2021; 23(9) doi: 10.1016/j.jcyt.2020.11.004
|
| 42 |
Nur Signa A Gumilas, Ika M Harini, Thianty Sylviningrum, Wahyu Djatmiko, Lantip Rujito. Hepatitis B as hepatocellular carcinoma (HCC) risk factor in the south region of Java, Indonesia. Journal of Physics: Conference Series 2019; 1246(1) doi: 10.1088/1742-6596/1246/1/012013
|
| 43 |
Ahmed S. Alazzouni, Abdulla A. Mahmoud, Mohamed M. Omran, Ehab A. Essawy, Mohga S. Abdalla, Mohamed S. Abdelfattah. Inhibitory and ameliorative effect of heliomycin derived from actinomycete on induced hepatocellular carcinoma in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 2021; 394(6) doi: 10.1007/s00210-020-02043-5
|
| 44 |
Xuanbin Wang, Longchao Xiang, Hongliang Li, Ping Chen, Yibin Feng, Jingxuan Zhang, Nian Yang, Fei Li, Ye Wang, Quifang Zhang, Fang Li, Fengjun Cao. The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review. International Journal of Molecular Sciences 2015; 16(9) doi: 10.3390/ijms160922527
|
| 45 |
Jian Pu, Jianchu Wang, Zuoming Xu, Yuan Lu, Xianjian Wu, Yi Wu, Zesheng Shao, Qianli Tang, Huamei Wei. miR-632 Functions as Oncogene in Hepatocellular Carcinoma via Targeting MYCT1. Human Gene Therapy Clinical Development 2019; 30(2) doi: 10.1089/humc.2019.040
|
| 46 |
Younglan Lim, Nam-On Ku. Revealing the Roles of Keratin 8/18-Associated Signaling Proteins Involved in the Development of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(12) doi: 10.3390/ijms22126401
|
| 47 |
Apichat Kaewdech, Phunchai Charatcharoenwitthaya, Teerha Piratvisuth. Asian Perspective on Hepatitis B Virus and Hepatitis C Virus Elimination. Viruses 2024; 17(1) doi: 10.3390/v17010034
|
| 48 |
Hui-Wen Chan, Yi-Hsuan Lo, Deng-Yuan Chang, Jia-Je Li, Wen-Yi Chang, Chih-Hao Chen, Chih-Hsien Chang, Chuan-Lin Chen, Hsin-Ell Wang, Ren-Shyan Liu, Chun-Yi Wu. Radiometal-Labeled Chitosan Microspheres as Transarterial Radioembolization Agents against Hepatocellular Carcinoma. Gels 2022; 8(3) doi: 10.3390/gels8030180
|
| 49 |
Liang Ding, Xin-you Zhang, Di-yao Wu, Meng-ling Liu. Application of an extreme learning machine network with particle swarm optimization in syndrome classification of primary liver cancer. Journal of Integrative Medicine 2021; 19(5) doi: 10.1016/j.joim.2021.08.001
|
| 50 |
Shreyoshi Guha, Sancharan Acharya, Chandrabose Sureka, Chinnasamy Thirunavukkarasu. Azadirachta indica Leaf Extract Mediated Green Synthesized Vanadium Nanoparticles Exhibit Potent Anticancer Activity against Hepatocellular Carcinoma in Hep3B Cells and in vivo, Compared with Sorafenib and Combination Treatment. BioNanoScience 2026; 16(3) doi: 10.1007/s12668-026-02437-4
|
| 51 |
Tagari Samanta, Jun Hyoung Park, Benny Abraham Kaipparettu. Biosocial Determinants of Health Among Patients with Chronic Liver Disease and Liver Cancer. Cancers 2025; 17(5) doi: 10.3390/cancers17050844
|
| 52 |
Gayatri Gouda, Manoj Gupta, Ramakrishna Vadde. Epigenetic Regulations in Gastrointestinal Cancers. 2026; doi: 10.1016/B978-0-443-27765-8.00016-3
|
| 53 |
Gretja Schnell, Rakesh Tripathi, Preethi Krishnan, Jill Beyer, Thomas Reisch, Michelle Irvin, Tatyana Dekhtyar, Carolyn Setze, Lino Rodrigues‐Jr, Katia Alves, Margaret Burroughs, Rebecca Redman, Kazuaki Chayama, Hiromitsu Kumada, Christine Collins, Tami Pilot‐Matias. Resistance characterization of hepatitis C virus genotype 2 from Japanese patients treated with ombitasvir and paritaprevir/ritonavir. Journal of Medical Virology 2018; 90(1) doi: 10.1002/jmv.24923
|
| 54 |
Kwang‐Pil Ko, Aesun Shin, Sooyoung Cho, Sue K Park, Keun‐Young Yoo. Environmental contributions to gastrointestinal and liver cancer in the Asia–Pacific region. Journal of Gastroenterology and Hepatology 2018; 33(1) doi: 10.1111/jgh.14005
|
| 55 |
Fan Yang, Xiaofang Zheng, Sarene Koh, Jianxi Lu, Jintao Cheng, Panlong Li, Cong Du, Yunhao Chen, Xiaoyan Chen, Li Yang, Wanxin Chen, Regina Wanju Wong, Lu‑En Wai, Tingting Wang, Qi Zhang, Wenjie Chen. Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial. Hepatology International 2023; 17(4) doi: 10.1007/s12072-023-10524-x
|
| 56 |
Debojyoti Halder, Ashutosh Gupta, Subhasis Chakraborty, Partha Roy, Kalyan Kumar Sen. Upgraded theragnostic strategies of multivariate nano gold in the management of hepatocellular carcinoma. Nano-Structures & Nano-Objects 2024; 40 doi: 10.1016/j.nanoso.2024.101342
|
| 57 |
Zhuoyang Fan, Bowen Yin, Xiaochen Chen, Guowei Yang, Wei Zhang, Xiaodan Ye, Hong Han, Ming Li, Minfeng Shu, Rong Liu. Comprehensive analysis of paraspeckle-associated gene modules unveils prognostic signatures and immunological relevance in multi-cancers. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01188-6
|
| 58 |
Piotr Starnawski, Klaudia Nowak, Zuzanna Augustyn, Dominik Malicki, Aleksandra Piąta, Dominika Lorek, Jakub Janczura. Role of hepatotropic viruses in promoting hepatocellular carcinoma—current knowledge and recent advances. Medical Oncology 2025; 42(4) doi: 10.1007/s12032-025-02674-9
|
| 59 |
Tiago Felismino, Luanna Martins, Matheus Barroso, Daniela Carvalho, Angelo Brito, Claudia Maccali, Felipe Coimbra. Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Biomarker in Advanced Hepatocellular Carcinoma Treated with First-Line Immunotherapy. Journal of Gastrointestinal Cancer 2025; 56(1) doi: 10.1007/s12029-025-01299-5
|
| 60 |
Yingqi She, Qinfeng Huang, Zhen Ye, Yu Hu, Mingquan Wu, Kaihua Qin, Ailing Wei, Xin Yang, Yuyao Liu, Cuihan Zhang, Qiaobo Ye. The Therapeutic Principle of Combined Strengthening Qi and Eliminating Pathogens in Treating Middle-Advanced Primary Liver Cancer: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.714287
|
| 61 |
Swetha Pulakuntla, Shri Abhiav Singh, Vaddi Damodara Reddy. Hub gene identification and immune infiltration analysis in hepatocellular carcinoma: Computational approach. In Silico Pharmacology 2024; 12(1) doi: 10.1007/s40203-024-00215-2
|
| 62 |
Michael R. Charlton, Altaf Alam, Akash Shukla, Bekhbold Dashtseren, Cosmas Rinaldi Adithya Lesmana, Davadoorj Duger, Diana Alcantara Payawal, Do Duy Cuong, Ganbolor Jargalsaikhan, Ian Homer Yee Cua, Jose Decena Sollano, Karam Romeo Singh, Kaushal Madan, Khin Maung Win, Khin Pyone Kyi, Kyaw Soe Tun, Mohd. Salih, Mukul Rastogi, Neeraj Saraf, Pham Thi Thu Thuy, Pham Tran Dieu Hien, Rino Alvani Gani, Rosmawati Mohamed, Tawesak Tanwandee, Teerha Piratvisuth, Wattana Sukeepaisarnjaroen, Win Naing, Zahid Yasin Hashmi. An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia. Journal of Gastroenterology 2020; 55(9) doi: 10.1007/s00535-020-01698-4
|
| 63 |
Shivlal Yadav, Alpana Ram. Formulation and In vitro Characterization of Linalool and Curcumin CO-Loaded Microparticulate System for Hepatocellular Carcinoma. Research Journal of Pharmacy and Technology 2024; doi: 10.52711/0974-360X.2024.00408
|
| 64 |
Zeying Gan, Tingyuan Fan, Wenjuan Wang, Xiao Qiao, Mingming Zhao, Hao Zhang. Integrative Genomic Analysis Reveals Pseudouridine Modification–Related Gene Signatures Associated With Prognosis and Therapeutic Response Patterns in Hepatocellular Carcinoma. International Journal of Genomics 2026; 2026(1) doi: 10.1155/ijog/9654215
|
| 65 |
Kalaivani Buskaran, Mohd Zobir Hussein, Mohamad Aris Mohd Moklas, Mas Jaffri Masarudin, Sharida Fakurazi. Graphene Oxide Loaded with Protocatechuic Acid and Chlorogenic Acid Dual Drug Nanodelivery System for Human Hepatocellular Carcinoma Therapeutic Application. International Journal of Molecular Sciences 2021; 22(11) doi: 10.3390/ijms22115786
|
| 66 |
Eric David Ornos, Karl Jeffrey Murillo, Janus P. Ong. Liver diseases: Perspective from the Philippines. Annals of Hepatology 2023; 28(3) doi: 10.1016/j.aohep.2023.101085
|
| 67 |
Yefan Zhu, Liang Zhao, Keqing Shi, Zitao Huang, Bicheng Chen. TRIM24 promotes hepatocellular carcinoma progression via AMPK signaling. Experimental Cell Research 2018; 367(2) doi: 10.1016/j.yexcr.2018.04.006
|
| 68 |
Benjiao Gong, Yanlei Kao, Chenglin Zhang, Fudong Sun, Huishan Zhao, Kuzhuvelil B. Harikumar. Systematic Investigation of Scutellariae Barbatae Herba for Treating Hepatocellular Carcinoma Based on Network Pharmacology. Evidence-Based Complementary and Alternative Medicine 2018; 2018(1) doi: 10.1155/2018/4365739
|
| 69 |
Deborah A Boyle. Hepatocellular carcinoma: Implications for Asia-Pacific Oncology Nurses. Asia-Pacific Journal of Oncology Nursing 2017; 4(2) doi: 10.4103/2347-5625.204497
|
| 70 |
Haopeng Zhang, Jiaren Liu, Guodong Li, Jiufeng Wei, Hongsheng Chen, Chunpeng Zhang, Jinlu Zhao, Yunfeng Wang, Shuwei Dang, Xinglong Li, Xuan Fang, Lianxin Liu, Ming Liu. Fresh red raspberry phytochemicals suppress the growth of hepatocellular carcinoma cells by PTEN/AKT pathway. The International Journal of Biochemistry & Cell Biology 2018; 104 doi: 10.1016/j.biocel.2018.09.003
|
| 71 |
Abolfazl Jafari-Sales, Safa Meskini-Marandi, Shabnam Khakpour-Ziaei, Sadra Valipour, Mehrdad Pashazadeh. The hidden yet threatening link between hepatitis B virus and hepatocellular carcinoma: A Narrative Review. Journal of Clinical and Basic Research 2025; 9(2) doi: 10.66224/JCBR.9.2.21
|
| 72 |
Sukanta Dutta, Atanu Chandra, Saikot Ganai, Uddalak Chakraborty, Sumesh PM. Metastasis to the skull base involving the sphenoid and cavernous sinus in hepatocellular carcinoma. Journal of the Royal College of Physicians of Edinburgh 2024; 54(3) doi: 10.1177/14782715241270368
|
| 73 |
N-Substituted Pyrido-1,4-Oxazin-3-Ones Induce Apoptosis of Hepatocellular Carcinoma Cells by Targeting NF-κB Signaling Pathway. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01125
|
| 74 |
Yaguang Qin, Hong Lu. In vitro evaluation of anti-hepatoma activity of brevilin A: involvement of Stat3/Snail and Wnt/β-catenin pathways. RSC Advances 2019; 9(8) doi: 10.1039/C8RA08574A
|
| 75 |
Nicole Cheng, Nathanelle Khoo, Alexander Y. F. Chung, Brian K. P. Goh, Peng Chung Cheow, Pierce K. H. Chow, Ser Yee Lee, London L. Ooi, Prema Raj Jeyaraj, Juinn Huar Kam, Ye Xin Koh, Chung Yip Chan, Jin Yao Teo. Pre‐operative Imaging Characteristics in Histology‐Proven Resected Intrahepatic Cholangiocarcinoma. World Journal of Surgery 2020; 44(11) doi: 10.1007/s00268-020-05698-6
|
| 76 |
Nilesh Rai, Anurag Kumar Singh, Priyanka Kumari Keshri, Suvakanta Barik, Swapnil C. Kamble, Santosh Kumar Singh, Rajiv Kumar, Pradeep Mishra, Deepak Kotiya, Vibhav Gautam. Probiotic Research in Therapeutics. 2021; doi: 10.1007/978-981-15-8214-1_9
|
| 77 |
Bita Moudi, Mohammad-Reza Mohades, Hamidreza Mahmoudzadeh-Sagheb, Zahra Heidari. Immunohistochemical expression of CB1 receptors in the liver of patients with HBV related-HCC. Arab Journal of Gastroenterology 2023; 24(1) doi: 10.1016/j.ajg.2022.10.002
|
| 78 |
Francisco Diaz-Mitoma, Vlad Popovic, Johanna N. Spaans. Assessment of immunogenicity and safety across two manufacturing lots of a 3-antigen hepatitis B vaccine, Sci-B-Vac®, compared with Engerix-B® in healthy Asian adults: A phase 3 randomized clinical trial. Vaccine 2021; 39(29) doi: 10.1016/j.vaccine.2021.05.067
|
| 79 |
Vinh Vu Hai, Yusuke Shimakawa, Jin Kim, Hai Do Ngoc, Quang Le Minh, Didier Laureillard, Maud Lemoine. Assessment and Simplification of Treatment Eligibility Among Patients With Chronic Hepatitis B Infection in Vietnam. Clinical Infectious Diseases 2021; 73(5) doi: 10.1093/cid/ciaa1814
|
| 80 |
Jia Xu, Chang Liu, Kai Qu, Jingyao Zhang, Sinan Liu, Fandi Meng, Yong Wan. m6A methyltransferase METTL14‑mediated RP1‑228H13.5 promotes the occurrence of liver cancer by targeting hsa‑miR‑205/ZIK1. Oncology Reports 2024; 51(4) doi: 10.3892/or.2024.8718
|
| 81 |
Yi Rang Kim, Mi Ran Byun, Jin Woo Choi. Integrin α6 as an invasiveness marker for hepatitis B viral X-driven hepatocellular carcinoma. Cancer Biomarkers 2018; 23(1) doi: 10.3233/CBM-181498
|
| 82 |
Jiu Chen, Guolin Wu, Youdi Li. Evaluation of Serum Des-Gamma-Carboxy Prothrombin for the Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Meta-Analysis. Disease Markers 2018; 2018 doi: 10.1155/2018/8906023
|
| 83 |
Daisuke Mizushima, Tsunefusa Hayashida, Dung Hoai Thi Nguyen, Dung Thi Nguyen, Shoko Matsumoto, Junko Tanuma, Hiroyuki Gatanaga, Kinh Van Nguyen, Shinichi Oka. Possible association of <i>HLA-DP</i> polymorphism and antiretroviral therapy with hepatitis B virus clearance in an HIV-infected Vietnamese population. Global Health & Medicine 2022; 4(3) doi: 10.35772/ghm.2021.01113
|
| 84 |
Wenhui Bai, Li Cheng, Liangkun Xiong, Maoming Wang, Hao Liu, Kaihuan Yu, Weixing Wang. Identification of Prognostic Genes in Hepatocellular Carcinoma. International Journal of General Medicine 2022; doi: 10.2147/IJGM.S347535
|
| 85 |
Jie Pan, Yuan Lu, Shuai Zhang, Yueting Li, Jia Sun, Hua Chunhua Liu, Zipeng Gong, Jing Huang, Chuang Cao, Yonglin Wang, Yongjun Li, Ting Liu. Differential changes in the pharmacokinetics of doxorubicin in diethylnitrosamine-induced hepatocarcinoma model rats. Xenobiotica 2020; 50(10) doi: 10.1080/00498254.2020.1765049
|
| 86 |
Tali Shaltiel, Umut Sarpel, Andrea D. Branch. The adverse characteristics of hepatocellular carcinoma in the non‐cirrhotic liver disproportionately disadvantage Black patients. Cancer Medicine 2024; 13(3) doi: 10.1002/cam4.6654
|
| 87 |
Huamei Wei, Jianchu Wang, Zuoming Xu, Yuan Lu, Xianjian Wu, Chenyi Zhuo, Chuan Tan, Qianli Tang, Jian Pu. miR‐584‐5p regulates hepatocellular carcinoma cell migration and invasion through targeting KCNE2. Molecular Genetics & Genomic Medicine 2019; 7(6) doi: 10.1002/mgg3.702
|
| 88 |
Xiaoguang Wang, Xiaodan Yang, Fei Chen, Shaohan Wu, Zhengwei Song, Jianguo Fei, Giovanni Marasco. Hepatitis B Virus Reactivation Potential Risk Factors in Hepatocellular Carcinoma via Transcatheter Arterial Chemoembolization: A Retrospective Research. Canadian Journal of Gastroenterology and Hepatology 2021; 2021(1) doi: 10.1155/2021/8864655
|
| 89 |
Thomas Yau, David Tai, Stephen Lam Chan, Yi-Hsiang Huang, Su Pin Choo, Chiun Hsu, Tan To Cheung, Shi-Ming Lin, Wei Peng Yong, Joycelyn Lee, Thomas Leung, Tracy Shum, Cynthia S.Y. Yeung, Anna Yin-Ping Tai, Ada Lai Yau Law, Ann-Lii Cheng, Li-Tzong Chen. Systemic Treatment of Advanced Unresectable Hepatocellular Carcinoma after First-Line Therapy: Expert Recommendations from Hong Kong, Singapore, and Taiwan. Liver Cancer 2022; 11(5) doi: 10.1159/000525582
|
| 90 |
Juan-Juan Gu, Min Yao, Jie Yang, Yin Cai, Wen-Jie Zheng, Li Wang, Deng-Bing Yao, Deng-Fu Yao. Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis. World Journal of Gastroenterology 2017; 23(2): 256-264 doi: 10.3748/wjg.v23.i2.256
|
| 91 |
Li Li, Anqi Chen, Bingmi Liu, Hao Pan, Yanjie Yu, Yu Liu. Preparation and pharmacokinetics of glycyrrhetinic acid and cell transmembrane peptides modified with liposomes for liver targeted-delivery. Biomedical Materials 2022; 17(4) doi: 10.1088/1748-605X/ac6b73
|
| 92 |
Reza Malekzadeh, Hossein Poustchi. Liver Cancer in the Middle East. 2021; doi: 10.1007/978-3-030-78737-0_14
|